Compare Arqit Quantum Inc (ARQQ) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Arqit Quantum Inc vs Nuwellis Inc — how do they compare? Arqit Quantum Inc trades at $24.49 (market cap $392.69M), while Nuwellis Inc trades at $1.48 (market cap $522.76K). The key difference: Arqit Quantum Inc is far larger — about 751.2× Nuwellis Inc's market cap, and Arqit Quantum Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| ARQQ | NUWE | |
|---|---|---|
Market Cap | $392.69M | $522.76K |
Sector | Technology | Technology |
52-Week High | $58.27 | $220.50 |
52-Week Low | $11.78 | $1.42 |
Enterprise Value | $366.00M | -$1.29M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARQQ trades at $22.90, up 6.66% with bullish technical signals from moving averages and ADX indicators. The company shows explosive revenue growth (829% YoY in H1 FY26) but remains deeply unprofitable with a -4,508% net margin and negative cash flow from operations. Recent news highlights quantum-safe encryption partnerships and government contract wins, though financial sustainability concerns persist.
The stock presents high-risk speculation on quantum security adoption versus fundamental weaknesses. Upside depends on commercializing technology into sustainable profits, while downside risks include cash burn and competitive threats. Analyst consensus is split 50/50 buy/hold with no institutional conviction evident in current financial metrics.
NUWE trades at $1.49, down 8.59% over the past day, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025, with a negative net income margin of -217.22%, though it has shown revenue growth and recent strategic expansions in pediatric care. A recent 35:1 reverse stock split was executed on June 26, 2026.
The outlook remains high-risk due to persistent losses and cash burn, but growth initiatives and new product development offer potential. Key risks include execution challenges and dependence on financing. Analyst sentiment is mixed, with a 50% buy and 50% hold rating among covered analysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Arqit Quantum Inc
Arqit Quantum provides advanced cybersecurity software that uses symmetric key agreement technology. Its solutions protect networked devices and data against current and future cyber threats, including quantum attacks.
Read more on ARQQ →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
